Date	July 16 (Sunday), 2023
President	Kinuko Mitani, MD, PhD (Department of Hematology and Oncology, Dokkyo Medical University, Japan)
Organizer	International Society of Hematology, Asian-Pacific Division Secretary-General：Takahiro Suzuki, MD, PhD (Department of Hematology, Kitasato University School of Medicine, Japan)

My name is Kinuko Mitani and am taking a role of chair of council in International Society of Hematology (ISH). It is my great honor to run the 1st Webinar of ISH as the president that will be delivered from Japan to the world.

ISH was founded in 1946 and is the oldest international hematology society concerned with advancing scientific research as well as the practice of hematology at both clinical and laboratory levels. ISH membership is open to any person with medical or scientific qualification of good professional standing in hematology. ISH has over 4,500 active members worldwide.

ISH has three divisions: Asian and Pacific Division (APD), European and African Division (EAD), Inter-American Division (IAD) and organizes the congress every other year with a rotation of the venue among APD, EAD and IAD. Last year, we had the ISH2022 congress in Barcelona, Spain, and will conduct the ISH2024 congress in Bangkok, Thailand. However, under a circumstance of the pandemic of COVID19 during these three years, our activities have been restricted so much. This time, we have planed the 1st Webinar to enhance our activities and make all the hematologists in the world get together.

Main topic of the 1st Webinar is “bone marrow failure syndrome”. We have scheduled three symposia (ASH-ISH joint, EHA-ISH joint, and Asian Symposium) and three sponsored seminars for aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes. Although registration is required, we will not collect registration fee and welcome all the hematologists in the world.

Considering the time difference, major part of participants may come from the AP division. However, we hope that this Webinar will provide a great opportunity for exchange of hematologists all over the world.

February 4, 2023

ASH-ISH Joint Session：Congenital Bone Marrow Failure Syndromes

9:00-10:30 (JST) 0:00-1:30 (UTC)

Chair：	Miguel HerreraCV（Bone Marrow Transplant Program at Hospital Lomas de San Luis, Mexico）
Decoding Inherited Bone Marrow Failure Syndromes: Bridging the Gap between Genetic Analysis and Clinical Diagnosis
Speaker：	Hideki MuramatsuCVAbstracts （Department of Pediatrics, Nagoya University Graduate School of Medicine, Japan）
Congenital Neutropenia Syndromes – from Pathogenesis to Leukemic Transformation
Speaker：	Julia T. WarrenCVAbstracts （University of Pennsylvania, Children’s Hospital of Philadelphia, USA）
Comprehensive Genomics in Bone Marrow Failure: from Diagnosis to Therapy Stratification
Speaker：	Marcin WlodarskiCVAbstracts （Department of Hematology, St. Jude Children’s Research Hospital, Memphis, USA）

Sponsored Session: AA Sponsored by Novartis Pharma K.K.

10:45-11:15 (JST) 1:45-2:15 (UTC)

Chair：	Hiroki YamaguchiCV （Department of Hematology, Nippon Medical School, Japan）
Recent advances in the treatment of aplastic anemia
Speaker：	Kohei HosokawaCVAbstracts （Department of Hematology, Kanazawa University Hospital, Japan）

Sponsored Session: PNH Sponsored by Alexion Pharma GK

11:30-12:00 (JST) 2:30-3:00 (UTC)

Chair：	Itaru MatsumuraCV （Department of Hematology and Rheumatology, Kindai University Faculty of Medicine, Japan）
PNH in Bone Marrow Failure
Speaker：	Jun-ichi NishimuraCVAbstracts （Department of Hematology and Oncology, Osaka University, Japan）

Asian Session：Therapy for AA in Asia

13:00-14:30 (JST) 4:00-5:30 (UTC)

Chair：	Takahiro SuzukiCV （Department of Hematology, Kitasato University School of Medicine, Japan）
Immunosuppressive therapy and anabolic hormone treatment for aplastic anemia; A lesson learned from Thailand
Speaker：	Lalita NorasetthadaCVAbstracts （Division of Hematology, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand）
Unmet needs in Severe Aplastic anemia
Speaker：	Dheepa ChristopherCVAbstracts （Department of Haematology, Tan Tock Seng Hospital, Singapore）
Management of severe aplastic anemia in Taiwan, from the perspective of real-world evidence
Speaker：	Yu-Chin HungCVAbstracts （Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Hu-Wei Region, Taiwan）
Management of Aplastic Anemia in East Malaysia
Speaker：	Lily Wong Lee LeeCVAbstracts （Department of Hematology, Hospital Queen Elizabeth, Malaysia）
Current treatment of aplastic anemia patients in Japan
Speaker：	Naoshi ObaraCVAbstracts （Department of Hematology, University of Tsukuba, Japan）

Sponsored Session: MDS Sponsored by AbbVie GK

14:45-15:15 (JST) 5:45-6:15 (UTC)

Chair：	Koichi AkashiCV （Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Japan）
Predisposition to Myeloid Neoplasms caused by Germline DDX41 Variants
Speaker：	Seishi OgawaCVAbstracts （Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan）

EHA-ISH Joint Session：Recent Progresses in the Therapy of MDS

15:30-17:00 (JST) 6:30-8:00 (UTC)

Chair：	Sabri KemahliCV （Pediatrics and Pediatric Hematology, Yeditepe University Faculty of Medicine, Istanbul, Turkey）
Novel Approaches in Lower-risk MDS
Speaker：	Uwe PlatzbeckerCVAbstracts （Department of Hematology, Cellular Therapy and Hemostaseology, University Hospital Leipzig, Germany）
Recent Progress in the Treatment of Lower Risk MDS
Speaker：	Pierre FenauxCV （Département (DMU) d’hématologie et immunologie, APHP Nord, Service d'hématologie séniors, Hôpital St Louis, université de Paris, France）
Clinical Trials for HR-MDS in Japan Adult Leukemia Study Group
Speaker：	Yasushi MiyazakiCVAbstracts （Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Japan）